Groff North America Revenue and Competitors
Estimated Revenue & Valuation
- Groff North America's estimated annual revenue is currently $2.6M per year.
- Groff North America's estimated revenue per employee is $155,000
Employee Data
- Groff North America has 17 Employees.
- Groff North America grew their employee count by -15% last year.
Groff North America's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Quality Assurance and Compliance (FDA/DEA) | Reveal Email/Phone |
3 | Production Director | Reveal Email/Phone |
4 | Executive Assistant | Reveal Email/Phone |
5 | Business Development Specialist | Reveal Email/Phone |
6 | Founding Chairman | Reveal Email/Phone |
Groff North America Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Groff North America?
Groff NA Hemplex is a physician-owned, hemp-cannabis company focused on processing industrial hemp. We process and refine hemp for its beneficial compounds and materials to further benefit people and the planet. Hemplex specializes in science-based custom cannabinoid formulations to meet consumer and market needs. Through a combination of technology and human capital, we continue to develop innovative and proven products for our customers.
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 20 | 11% | N/A |
#2 | $4.9M | 24 | -49% | N/A |
#3 | $12.9M | 49 | 0% | N/A |
#4 | $77.9M | 346 | 4% | N/A |